US Patent 7674904 Synthesis of R-N-methylnaltrexone
Patent 7674904 was granted and assigned to Progenics Pharmaceuticals on March, 2010 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7674904 Synthesis of R-N-methylnaltrexone
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.